% | $
Quotes you view appear here for quick access.

ViroPharma Incorporated Message Board

  • kamoa_1 kamoa_1 Dec 16, 2012 1:24 PM Flag

    Deutch Bank and Oppenheimer CC- good stuff...

    maribavir- lots of excitement, other docs say past prophylactic study should have been for acute treatment and higher dose, recent study showed no viral load in 4 weeks of treatment... compelling results coming in-enough to consider going to FDA for a pow-wow for an early approval...

    plenadren - in early '13 they will have another FDA pow-wow... a homerun or a double?... will come to U.S. one way or another

    vp20621(nontox c-diff) - data ahead...
    Charlie says end of '13, but I think more on end of '12 early '13 for phase ii data... in line to what the says...

    c1-inh- lots of other uses, iis results are expected throughout '13 besides the companies own studies, amr and dgf, revealed that there is recombinant study going on with good progress, subq is going well, will take the co. to new horizons, imo...
    - had 760 patients at end of '11 expects to have over 900 on years end... that's a run rate of ~150 per year... with addition of 4-8 reps and steroid users finally getting the drift, they are seeing no slow down...

    $227 million buyback still in effect.

    much more stuffs... check it out.


    SortNewest  |  Oldest  |  Most Replied Expand all replies
49.96-0.01(-0.02%)Jan 23 4:00 PMEST